140 related articles for article (PubMed ID: 20090004)
1. Expanded postexposure prophylaxis for simultaneous multiple source HIV exposure in a health-care worker.
Baraboutis IG; Papastamopoulos V; Georgiou O; Samarkos M; Vrionis E; Kotsianopoulou M; Skoutelis AT
Int J STD AIDS; 2010 Feb; 21(2):147-8. PubMed ID: 20090004
[TBL] [Abstract][Full Text] [Related]
2. Induction therapy with enfuvirtide-based highly active antiretroviral therapy in a patient with acute HIV-1 infection.
Polk C; Chan-Tack KM; Kopack AM; Amoroso A
AIDS Patient Care STDS; 2007 Feb; 21(2):75-7. PubMed ID: 17328655
[No Abstract] [Full Text] [Related]
3. [HIV prophylaxis kits. A concept for emergency treatment in the context of postexposure prophylaxis].
Wicker S; Walcher F; Wutzler S; Marzi I; Stephan C
Chirurg; 2014 Jan; 85(1):60-2. PubMed ID: 24292193
[TBL] [Abstract][Full Text] [Related]
4. HIV exposure through contact with body fluids.
Prescrire Int; 2012 Apr; 21(126):100-1, 103-5. PubMed ID: 22515138
[TBL] [Abstract][Full Text] [Related]
5. [HIV post exposure prophylaxis therapy - the experience of two major AIDS centers].
Elbirt D; Levy I; Asher I; Mahlev-Guri K; Rosenberg-Bezalet S; Litachevsky S; Radian-Sade S; Sthoeger Z
Harefuah; 2013 Apr; 152(4):224-9, 246. PubMed ID: 23844525
[TBL] [Abstract][Full Text] [Related]
6. Tolerability of two different combinations of antiretroviral drugs including tenofovir used in occupational and nonoccupational postexposure prophylaxis for HIV.
Burty C; Prazuck T; Truchetet F; Christian B; Penalba C; Salmon-Ceron D; Yazdanpanah Y; May T; Rabaud C
AIDS Patient Care STDS; 2010 Jan; 24(1):1-3. PubMed ID: 20095911
[No Abstract] [Full Text] [Related]
7. Occupational postexposure prophylaxis for HIV: The PEPline perspective.
Top HIV Med; 2010 Dec; 18(5):174-7. PubMed ID: 21245519
[TBL] [Abstract][Full Text] [Related]
8. Post-exposure prophylaxis for HIV.
Gathiram V
S Afr Med J; 2000 Apr; 90(4):346-51. PubMed ID: 10957915
[No Abstract] [Full Text] [Related]
9. Post-exposure prophylaxis with a maraviroc-containing regimen after occupational exposure to a multi-resistant HIV-infected source person.
Méchai F; Quertainmont Y; Sahali S; Delfraissy JF; Ghosn J
J Med Virol; 2008 Jan; 80(1):9-10. PubMed ID: 18041046
[TBL] [Abstract][Full Text] [Related]
10. Tolerability of HIV postexposure prophylaxis with tenofovir/emtricitabine and lopinavir/ritonavir tablet formulation.
Tosini W; Muller P; Prazuck T; Benabdelmoumen G; Peyrouse E; Christian B; Quertainmont Y; Bouvet E; Rabaud C
AIDS; 2010 Sep; 24(15):2375-80. PubMed ID: 20729709
[TBL] [Abstract][Full Text] [Related]
11. [Post-exposure HIV prevention within and outside the hospital].
Jost J
Ther Umsch; 1998 May; 55(5):289-94. PubMed ID: 9643126
[TBL] [Abstract][Full Text] [Related]
12. Should patients be compelled to undergo HIV testing after a needlestick injury involving a health care worker?
Ross JJ; Levangie D; Worthington MG
Pharos Alpha Omega Alpha Honor Med Soc; 2006; 69(1):32-6. PubMed ID: 16544462
[No Abstract] [Full Text] [Related]
13. [Occupational exposure to HIV in health care workers, Silesia voivodeship].
Braczkowska B; Kowalska M; Beniowski M; Zejda JE; Mazur W; Witor A
Med Pr; 2010; 61(3):315-22. PubMed ID: 20677431
[TBL] [Abstract][Full Text] [Related]
14. [Post-exposure prevention of HIV infection].
Möst J
Wien Med Wochenschr; 1998; 148(23-24):547-9. PubMed ID: 10189684
[TBL] [Abstract][Full Text] [Related]
15. Risk to the health care worker of HIV infection and how to minimize It.
Cheung RJ; DiMarino AJ
Gastrointest Endosc Clin N Am; 1998 Oct; 8(4):769-82. PubMed ID: 9730931
[TBL] [Abstract][Full Text] [Related]
16. Postexposure prophylaxis for HIV.
Daily JP
AIDS Clin Care; 1997 Aug; 9(8):59-61, 66. PubMed ID: 11364478
[TBL] [Abstract][Full Text] [Related]
17. The effects of a nucleoside-sparing antiretroviral regimen on the pharmacokinetics of ritonavir-boosted darunavir in HIV type-1-infected patients.
Garvey L; Latch N; Erlwein OW; Mackie NE; Walsh J; Scullard G; McClure MO; Dickinson L; Back D; Winston A
Antivir Ther; 2010; 15(2):213-8. PubMed ID: 20386076
[TBL] [Abstract][Full Text] [Related]
18. Post-exposure prophylaxis for human immunodeficiency virus infection in the Royal Infirmary of Edinburgh--an audit.
Manavi K; McMillan A; Paterson J
Int J STD AIDS; 2004 Feb; 15(2):134-8. PubMed ID: 15006077
[TBL] [Abstract][Full Text] [Related]
19. [Postexposure prophylaxis after occupational exposure to HBV, HCV and HIV].
Sarrazin U; Brodt R; Sarrazin C; Zeuzem S
Radiologe; 2004 Feb; 44(2):181-94. PubMed ID: 14991139
[TBL] [Abstract][Full Text] [Related]
20. Raltegravir: new Drug. Alternative to enfuvirtide/darunavir in multidrug-resistant HIV.
Prescrire Int; 2008 Aug; 17(96):135-7. PubMed ID: 19480091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
